Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Adenosine A2A receptor antagonists: from caffeine to selective non‐xanthines
Kenneth A. Jacobson, Zhan‐Guo Gao, Pierre Matricon, et al.
British Journal of Pharmacology (2020) Vol. 179, Iss. 14, pp. 3496-3511
Open Access | Times Cited: 69

Showing 1-25 of 69 citing articles:

Structure-Based Virtual Screening for Ligands of G Protein–Coupled Receptors: What Can Molecular Docking Do for You?
Flavio Ballante, Albert J. Kooistra, Stefanie Kampen, et al.
Pharmacological Reviews (2021) Vol. 73, Iss. 4, pp. 1698-1736
Open Access | Times Cited: 104
Recent advances on white tea: Manufacturing, compositions, aging characteristics and bioactivities
Su Zhou, Jinming Zhang, Shicheng Ma, et al.
Trends in Food Science & Technology (2023) Vol. 134, pp. 41-55
Closed Access | Times Cited: 50
The Medicinal Chemistry of Caffeine
Giuseppe Faudone, Silvia Arifi, Daniel Merk
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 11, pp. 7156-7178
Closed Access | Times Cited: 94
Caffeine Protects Against Retinal Inflammation
Federica Conti, Francesca Lazzara, Giovanni Luca Romano, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 30
Purinergic signaling: A gatekeeper of blood-brain barrier permeation
Yuemei Wang, Yuanbing Zhu, Jun‐Meng Wang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 20
Synergistic Effects of Caffeine in Combination with Conventional Drugs: Perspectives of a Drug That Never Ages
Davide Ialongo, Valeria Tudino, Merve Arpacioglu, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 5, pp. 730-730
Open Access | Times Cited: 18
Efficacy of therapies for post dural puncture headache
Jan N. Thon, Markus A. Weigand, Peter Kranke, et al.
Current Opinion in Anaesthesiology (2024) Vol. 37, Iss. 3, pp. 219-226
Open Access | Times Cited: 7
Membrane mimetic-dependence of GPCR energy landscapes
Naveen Thakur, Arka Prabha Ray, Beining Jin, et al.
Structure (2024) Vol. 32, Iss. 5, pp. 523-535.e5
Open Access | Times Cited: 6
Beyond AOPs: A Mechanistic Evaluation of NAMs in DART Testing
Ramya Rajagopal, Maria Teresa Baltazar, Paul L. Carmichael, et al.
Frontiers in Toxicology (2022) Vol. 4
Open Access | Times Cited: 27
Role of Antioxidants of Natural Herbs in Management of Male Infertility
Gaznee, Ashna Kohli, Roshan Kumar
Journal for Research in Applied Sciences and Biotechnology (2023) Vol. 2, Iss. 1, pp. 55-80
Open Access | Times Cited: 16
Dual-effects of caffeinated hyalurosomes as a nano-cosmeceutical gel counteracting UV-induced skin ageing
Manal A Elsheikh, Passent M.E. Gaafar, Mohamed A. Khattab, et al.
International Journal of Pharmaceutics X (2023) Vol. 5, pp. 100170-100170
Open Access | Times Cited: 13
Unlocking the adenosine receptor mechanism of the tumour immune microenvironment
Yecheng Han, Chenshuang Dong, Mingwang Hu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Medicinal chemistry of P2 and adenosine receptors: Common scaffolds adapted for multiple targets
Kenneth A. Jacobson, Adriaan P. IJzerman, Christa E. Müller
Biochemical Pharmacology (2020) Vol. 187, pp. 114311-114311
Open Access | Times Cited: 36
A2A Adenosine Receptor as a Potential Biomarker and a Possible Therapeutic Target in Alzheimer’s Disease
Stefania Gessi, Tino Emanuele Poloni, G Negro, et al.
Cells (2021) Vol. 10, Iss. 9, pp. 2344-2344
Open Access | Times Cited: 29
Upregulation of Cortical A2A Adenosine Receptors Is Reflected in Platelets of Patients with Alzheimer’s Disease
Stefania Merighi, Enrica Battistello, Ilaria Casetta, et al.
Journal of Alzheimer s Disease (2021) Vol. 80, Iss. 3, pp. 1105-1117
Closed Access | Times Cited: 28
A2A Adenosine Receptor Antagonists in Neurodegenerative Diseases
Stefania Merighi, Pier Andrea Borea, Katia Varani, et al.
Current Medicinal Chemistry (2021) Vol. 29, Iss. 24, pp. 4138-4151
Open Access | Times Cited: 28
Pathophysiological Role and Medicinal Chemistry of A2A Adenosine Receptor Antagonists in Alzheimer’s Disease
Stefania Merighi, Pier Andrea Borea, Katia Varani, et al.
Molecules (2022) Vol. 27, Iss. 9, pp. 2680-2680
Open Access | Times Cited: 22
In Vitro Pharmacological Profile of KW-6356, a Novel Adenosine A2AReceptor Antagonist/Inverse Agonist
Yutaro Ohno, Michihiko Suzuki, Hidetsugu Asada, et al.
Molecular Pharmacology (2023) Vol. 103, Iss. 6, pp. 311-324
Closed Access | Times Cited: 12
Development of an In Situ G Protein-Coupled Receptor Fragment Molecule Screening Approach with High-Resolution Magic Angle Spinning Nuclear Magnetic Resonance
Enzo Petracco, Guillaume Ferré, Ivo Kabelka, et al.
ACS Chemical Biology (2025)
Closed Access
Anti-Proliferative Activity of Ethylenediurea Derivatives with Alkyl and Oxygen-Containing Groups as Substituents
Maxim Oshchepkov, L. V. Kovalenko, Antonida V. Kalistratova, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 316-316
Open Access
The Role of Xenobiotic Caffeine on Cardiovascular Health: Promises and Challenges
Roberto Campagna, Arianna Vignini
Journal of Xenobiotics (2025) Vol. 15, Iss. 2, pp. 51-51
Open Access
Insights from Clinical Trials on A2A Adenosine Receptor Antagonists for Cancer Treatment
Pran Kishore Deb, Prasenjit Maity, Biprajit Sarkar, et al.
ACS Pharmacology & Translational Science (2025)
Closed Access
Pivotal Role of Fyn Kinase in Parkinson’s Disease and Levodopa-Induced Dyskinesia: a Novel Therapeutic Target?
Efthalia Angelopoulou, Yam Nath Paudel, Thomas Julian, et al.
Molecular Neurobiology (2020) Vol. 58, Iss. 4, pp. 1372-1391
Closed Access | Times Cited: 30
Caffeine: The Story beyond Oxygen-Induced Lung and Brain Injury in Neonatal Animal Models—A Narrative Review
Stefanie Endesfelder
Antioxidants (2024) Vol. 13, Iss. 9, pp. 1076-1076
Open Access | Times Cited: 3
Macamides as Potential Therapeutic Agents in Neurological Disorders
Karin J. Vera-López, Gonzalo Dávila-Del-Carpio, Rita Nieto-Montesinos
Neurology International (2024) Vol. 16, Iss. 6, pp. 1611-1625
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top